About IMNN-001 Immunotherapy Designed using IMUNON's proprietary TheraPlas® platform technology, IMNN-001 is an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that enables ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

The company has established an integrated R&D platform encompassing sequence design, chemical modification, and drug delivery ... selected-for-ats-2025-oral-presentation-demonstrating-world ...

TAIPEI, May 16, 2025 /PRNewswire/ -- The broad-spectrum antiviral siRNA drug SNS812, co-developed by Oneness Biotech (4743.TW) and Microbio (Shanghai), has been selected for oral presentation ... and ...

About IMNN-001 Immunotherapy Designed using IMUNON's proprietary TheraPlas ® platform technology, IMNN-001 is an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that enables cell ...

Results are being highlighted in an oral presentation at the 2025 American ... an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that enables cell transfection followed by ...

Symeou Dental Center, a well-established dental clinic based in the heart of Nicosia, has announced the expansion of its ...

There was something about her body, but Mexican actress Eréndira Castorela couldn’t quite put her finger on it. Some casting ...

Be Biopharma, Inc. ("Be Bio"), a clinical-stage company pioneering the discovery and development of engineered B Cell ...